Company Information
USD
97.8
- (-0.6%)
NASDAQ:JAZZ, JAZZ PHARMACEUTICALS PLC
Industry: Biotechnology
End of Day: 9 May 2025 GMT-4
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Address
Waterloo Road
Fifth Floor, Waterloo Exchange
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Patrick Thomas Kennedy
Director
Mr. Peter P. Gray
Director
Mr. Philip L. Johnson
CFO/Executive VP
Ms. Patricia Carr
Chief Accounting Officer/Senior VP
Mr. Bruce C. Cozadd
CEO/Chairman of the Board/Co-Founder/Director
Mr. Patrick G. Enright
Director
Dr. Norbert G. Riedel,PhD
Director
Mr. Rick E. Winningham
Director
Ms. Heather Ann McSharry
Director
Mr. Kenneth W. O'Keefe
Director
Mr. Seamus C. Mulligan
Director
Dr. Catherine Angell Sohn, Pharm.D.
Director
Ms. Renee D. Gala
COO/President
Ms. Jennifer E. Cook
Director
Ms. Anne O'Riordan
Director
Dr. Mark D. Smith, M.D.
Director
Dr. Robert Iannone, M.D.
Executive VP/Other Corporate Officer
Ms. Neena M. Patil
Chief Legal Officer/Executive VP
Dr. Finbar Larkin, PhD
Senior VP, Divisional
Ms. Samantha Pearce
Senior VP, Geographical
Ownership
Institution Holdings
BlackRock Inc
7,056,032 (11.318%)
Vanguard Group Inc
6,363,748 (10.207%)
BlackRock Fund Advisors
3,601,483 (5.777%)
State Street Corporation
2,421,125 (3.883%)
LSV Asset Management
2,343,227 (3.758%)
Vanguard Investments Australia Ltd
1,931,599 (3.098%)
Fidelity Management & Research Company LLC
1,729,633 (2.774%)
JPMorgan Chase & Co
1,397,284 (2.241%)
Ameriprise Financial Inc
1,312,771 (2.106%)
Columbia Mgmt Investment Advisers, LLC
1,312,771 (2.106%)
Individual Holdings
Mr. Seamus C. Mulligan
1,172,375 (1.857%)
Mr. Bruce C. Cozadd
452,245 (0.725%)
Dr. Robert Iannone, M.D.
66,520 (0.107%)
Ms. Renee D. Gala
60,715 (0.097%)
Ms. Neena M. Patil
45,061 (0.072%)
Mr. Philip L. Johnson
27,932 (0.045%)
Mr. Kenneth W. O'Keefe
24,723 (0.039%)
Mr. Patrick G. Enright
20,946 (0.033%)
Ms. Samantha Pearce
19,396 (0.031%)
Ms. Heather Ann McSharry
16,778 (0.027%)
Funds Holdings
iShares Core S&P Mid-Cap ETF
1,916,548 (3.074%)
Vanguard US Total Market Shares ETF
1,894,882 (3.039%)
Vanguard Total Stock Market Index Fund
1,894,882 (3.039%)
Vanguard Small Cap Index
1,527,337 (2.450%)
Pacer US Cash Cows 100 ETF
1,088,168 (1.745%)
Vanguard Small Cap Value Index Fund
1,046,342 (1.678%)
Vanguard Institutional Extnd Mkt Idx Tr
928,937 (1.490%)
JPM US Mid Cap Value-Composite
873,205 (1.401%)
SPDR® S&P MIDCAP 400 ETF Trust
500,948 (0.804%)
Polaris Capital Mgt - Polaris Intl Eq
425,460 (0.682%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
